Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1526

1.

Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer.

Kemeny N, Capanu M, D'Angelica M, Jarnagin W, Haviland D, Dematteo R, Fong Y.

Ann Oncol. 2009 Jul;20(7):1236-41. doi: 10.1093/annonc/mdn769. Epub 2009 Feb 20.

PMID:
19233901
[PubMed - indexed for MEDLINE]
Free Article
2.

Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer.

Kemeny N, Jarnagin W, Paty P, Gönen M, Schwartz L, Morse M, Leonard G, D'Angelica M, DeMatteo R, Blumgart L, Fong Y.

J Clin Oncol. 2005 Aug 1;23(22):4888-96. Epub 2005 Jul 11.

PMID:
16009951
[PubMed - indexed for MEDLINE]
Free Article
3.

Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer.

Kemeny N, Jarnagin W, Gonen M, Stockman J, Blumgart L, Sperber D, Hummer A, Fong Y.

J Clin Oncol. 2003 Sep 1;21(17):3303-9.

PMID:
12947066
[PubMed - indexed for MEDLINE]
4.

A pilot study of hepatic artery floxuridine combined with systemic 5-fluorouracil and leucovorin. A potential adjuvant program after resection of colorectal hepatic metastases.

Kemeny N, Conti JA, Sigurdson E, Cohen A, Seiter K, Lincer R, Niedzwiecki D, Botet J, Chapman D, Costa P, et al.

Cancer. 1993 Mar 15;71(6):1964-71.

PMID:
8443746
[PubMed - indexed for MEDLINE]
6.

Continuous delivery of venous 5-fluorouracil and arterial 5-fluorodeoxyuridine for hepatic metastases from colorectal cancer: feasibility and tolerance in a randomized phase II trial comparing flat versus chronomodulated infusion.

Focan C, Levi F, Kreutz F, Focan-Henrard D, Lobelle JP, Adam R, Dallemagne B, Jehaes C, Markiewicz S, Weerts J, Bismuth H, Jasmin C, Misset JL.

Anticancer Drugs. 1999 Apr;10(4):385-92.

PMID:
10378673
[PubMed - indexed for MEDLINE]
7.

Phase II trial of hepatic arterial infusion of fluorouracil and recombinant human interferon alfa-2b for liver metastases of colorectal cancer refractory to systemic fluorouracil and leucovorin.

Patt YZ, Hoque A, Lozano R, Pozdur R, Chase J, Carrasco H, Chuang V, Delpassand ES, Ellis L, Curley S, Roh M, Jones DV Jr.

J Clin Oncol. 1997 Apr;15(4):1432-8.

PMID:
9193336
[PubMed - indexed for MEDLINE]
8.

Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.

Ducreux M, Ychou M, Laplanche A, Gamelin E, Lasser P, Husseini F, Quenet F, Viret F, Jacob JH, Boige V, Elias D, Delperro JR, Luboinski M; gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.

J Clin Oncol. 2005 Aug 1;23(22):4881-7. Epub 2005 Jul 11.

PMID:
16009952
[PubMed - indexed for MEDLINE]
Free Article
9.

Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update.

Kemeny N, Seiter K, Conti JA, Cohen A, Bertino JR, Sigurdson ER, Botet J, Chapman D, Mazumdar M, Budd AJ.

Cancer. 1994 Feb 15;73(4):1134-42.

PMID:
8313315
[PubMed - indexed for MEDLINE]
10.

Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.

Kemeny N, Huang Y, Cohen AM, Shi W, Conti JA, Brennan MF, Bertino JR, Turnbull AD, Sullivan D, Stockman J, Blumgart LH, Fong Y.

N Engl J Med. 1999 Dec 30;341(27):2039-48.

PMID:
10615075
[PubMed - indexed for MEDLINE]
Free Article
11.

Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer.

House MG, Kemeny NE, Gönen M, Fong Y, Allen PJ, Paty PB, DeMatteo RP, Blumgart LH, Jarnagin WR, D'Angelica MI.

Ann Surg. 2011 Dec;254(6):851-6. doi: 10.1097/SLA.0b013e31822f4f88.

PMID:
21975318
[PubMed - indexed for MEDLINE]
12.

Alternating hepatic arterial infusion and systemic chemotherapy for liver metastases from colorectal cancer: a phase II trial using intermittent percutaneous hepatic arterial access.

Copur MS, Capadano M, Lynch J, Goertzen T, McCowan T, Brand R, Tempero M.

J Clin Oncol. 2001 May 1;19(9):2404-12.

PMID:
11331319
[PubMed - indexed for MEDLINE]
13.

Hepatic arterial infusion chemotherapy using fluorouracil followed by systemic therapy using oxaliplatin plus fluorouracil and leucovorin for patients with unresectable liver metastases from colorectal cancer.

Seki H, Ozaki T, Shiina M.

Cardiovasc Intervent Radiol. 2009 Jul;32(4):679-86. doi: 10.1007/s00270-009-9547-1. Epub 2009 Mar 19.

PMID:
19296157
[PubMed - indexed for MEDLINE]
14.

A phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole after resection of high risk colon cancer.

Kelsen DP, Saltz L, Cohen AM, Yao TJ, Enker W, Tong W, Tao Y, Bertino JR.

Cancer. 1994 Oct 15;74(8):2224-33.

PMID:
7922973
[PubMed - indexed for MEDLINE]
15.

Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy.

Sharma RA, Van Hazel GA, Morgan B, Berry DP, Blanshard K, Price D, Bower G, Shannon JA, Gibbs P, Steward WP.

J Clin Oncol. 2007 Mar 20;25(9):1099-106.

PMID:
17369573
[PubMed - indexed for MEDLINE]
Free Article
16.

Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen)

Lorenz M, Müller HH, Schramm H, Gassel HJ, Rau HG, Ridwelski K, Hauss J, Stieger R, Jauch KW, Bechstein WO, Encke A.

Ann Surg. 1998 Dec;228(6):756-62.

PMID:
9860474
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver.

O'Connell MJ, Nagorney DM, Bernath AM, Schroeder G, Fitzgibbons RJ, Mailliard JA, Burch P, Bolton JS, Colon-Otero G, Krook JE.

J Clin Oncol. 1998 Jul;16(7):2528-33.

PMID:
9667274
[PubMed - indexed for MEDLINE]
18.

Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure.

Boige V, Malka D, Elias D, Castaing M, De Baere T, Goere D, Dromain C, Pocard M, Ducreux M.

Ann Surg Oncol. 2008 Jan;15(1):219-26. Epub 2007 Sep 26.

PMID:
17896145
[PubMed - indexed for MEDLINE]
19.

Intrahepatic chemotherapy with floxuridine, leucovorin and dexamethasone in continuous infusion and mitomycin-C bolus in unresectable hepatic metastases from colorectal cancer: a phase II study.

Bertuccelli M, Falcone A, Campoccia S, Conti M, Brunetti I, Caramella D, Giulianotti PC, Mosca F, Bartolozzi C, Conte PF.

Tumori. 1999 Nov-Dec;85(6):473-7.

PMID:
10774568
[PubMed - indexed for MEDLINE]
20.

Selective intra-arterial chemotherapy with floxuridine as second- or third-line approach in patients with unresectable colorectal liver metastases.

Samaras P, Breitenstein S, Haile SR, Stenner-Liewen F, Heinrich S, Feilchenfeldt J, Renner C, Knuth A, Pestalozzi BC, Clavien PA.

Ann Surg Oncol. 2011 Jul;18(7):1924-31. doi: 10.1245/s10434-010-1505-2. Epub 2011 Jan 5.

PMID:
21207165
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk